2030 Patients Treatment 
FloridaMarijuana.net
AUGUST 16, 2018
Dementia cannot be confirmed until a patient is deceased. Dementia is hard on the patient, and often harder on the family or caregivers. The Dementia Society of America attributes Dementia to rising healthcare costs as billions are spent each year for treatments and research. million in 2030. million in 2000 to 19.5
MGC Pharma
FEBRUARY 22, 2018
According to the Australian Bureau of Statistics, the number of people aged 65 years or older is expected to exceed the number of children aged 14 and below by as soon as 2030. A recent Hawaii-based study of 2,736 patients above the age of 65 found that, after six months, 93.7% namely Australia’s aging population.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 30, 2021
According to the Lancet Commission, mental health disorders are on the rise in every country worldwide, and the resulting lost productivity will cost the global economy $16 trillion by 2030. Let’s take a closer look at the challenges facing mental health treatments and how SHAMAN and psychedelics could play critical roles in improving them.
Cannabis Law Report
DECEMBER 17, 2021
Deletion Syndrome – Global Market Insights, Epidemiology and Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. deletion syndrome patient pool and forecasted trend for each seven major countries. during the study period (2018-2030). DUBLIN–(BUSINESS WIRE)–The “22q11.2
Cannabis Law Report
AUGUST 3, 2021
Unlike most other ailments, there isn’t a simple test that physicians can use to diagnose a patient with a disorder. Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. Medxtractor Corp. compound annual growth rate from $2.8
Cannabis Law Report
FEBRUARY 3, 2022
DUBLIN–(BUSINESS WIRE)–The “Global Cannabis Market- Market Size & Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. million by 2030 at a CAGR of 23.9%, 2021-2030. Growing Adoption of Medical Cannabis for the Treatment of Chronic Compounds. Restraints.
The Cannigma
OCTOBER 20, 2021
In a June, 2020 interview, a Swiss drug policy expert told Marijuana Business Daily that the scientific process behind the pilot program is expected to last five years, and that if everything goes as planned, the matter of full recreational cannabis legalization for adults could be debated by 2030. What Swiss law permits medical patients?
Expert insights. Personalized for you.
Let's personalize your content